The correlation between the aberrant overexpression of CCT3 and the poor prognosis of HCC patients has been shown, as has the depletion of CCT3 sensitized HCC cells to chemotherapy (Zhang et al., 2016). The gene discussed is CCT3; the disease is hepatocellular carcinoma.